EchoNous and Mendaera’s collaboration aims to make advanced technology accessible at the point of care. Credit: Rumka vodki via Shutterstock.

EchoNous and Mendaera have teamed up to combine their ultrasound and robotic technologies.  

The partnership aims to improve the way doctors perform certain important medical treatments by combining EchoNous’ ultrasound platform, dubbed Kosmos, with Mendaera’s handheld robotic tool. The companies said that these technologies are meant to help more healthcare providers perform procedures safely and accurately, regardless of medical specialty or location. 

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

EchoNous’ Kosmos platform includes a portable, artificial intelligence (AI)-based ultrasound device. The platform offers 2D imaging enhanced with pulse wave (PW), tissue doppler imaging (TDI), and continuous wave (CW) Doppler capabilities, as per EchoNous’ website.  

Silicon Valley-based company Mendaera secured $73m in funding in September to advance its handheld needle-based robot technology into areas of surgery such as biopsies, organ and vascular access, and pain management interventions. The company is developing a new robotic platform that integrates AI, real-time imaging, and virtual connectivity to assist with everyday medical procedures. 

Once commercialised, Mendaera will offer the EchoNous Kosmos ultrasound technology as an imaging option available to its robotic customers, as per the 8 October announcement. 

See Also:

Mendaera’s CEO Josh DeFonzo said: “Technology that empowers healthcare systems to improve care as well as the way it is delivered is especially critical for commonplace image-guided interventions across the healthcare system, where the supply and demand crisis is particularly acute. The EchoNous technology is an ideal complement to the Mendaera platform, providing high-quality imaging to our customers as they seek to provide the best care to their patients.” 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In a similar move, Mendaera entered into a partnership with Butterfly Network in December 2023. The goal of the agreement was to deliver an interventional robot that incorporates Butterfly’s semiconductor-based ultrasound technology and imaging software to help guide Mendaera’s needle-based procedures in real time. 

Last month, medical imaging software and devices company Exo launched SweepAI, an AI-based cardiac and lung scanning ultrasound application. The US Food and Drug Administration (FDA)-approved device provides instant feedback during organ scans, automatically identifying optimal imaging and offering diagnostic insights in real-time. 

According to a report on GlobalData’s Medical Intelligence Center, AI is set to unlock new cases for robotics, an industry that was worth $76bn in 2023. The market is forecast to grow at a compound annual growth rate (CAGR) of 14% to $218bn by 2030.